In contrast, the TCGA‐CRC cohort showed significantly higher mutation frequencies in the cell cycle (p value: <0.0001****) and TGF‐β (p value: 0.0035**) signaling pathways. This evidence concerns the gene TGFB1 and colorectal carcinoma.